서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2024-12	Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial Xu, Binghe; Wang, Shusen; Yan, Min; Sohn, Joohyuk; Li, Wei; Tang, Jinhai; Wang, Xiaojia; Wang, Ying; Im, Seock-Ah; Jiang, Dongdong; Valdez, Theresa; Dasgupta, Anandaroop; Zhang, Yiran; Yan, Yilin; Komatsubara, Kimberly M.; Chung, Wei-Pang; Ma, Fei; Dai, Ming-Shen Nature Medicine, Vol.30 No.12, pp.3709-3716	DOI
2025-01	Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01 Bardia, Aditya; Jhaveri, Komal; Im, Seock-Ah; Pernas, Sonia; De Laurentiis, Michelino; Wang, Shusen; Martinez Janez, Noelia; Borges, Giuliano; Cescon, David W.; Hattori, Masaya; Lu, Yen-Shen; Hamilton, Erika; Zhang, Qingyuan; Tsurutani, Junji; Kalinsky, Kevin; Rubini Liedke, Pedro Emanuel; Xu, Lu; Fairhurst, Rick M.; Khan, Sabrina; Denduluri, Neelima; Rugo, Hope S.; Xu, Binghe; Pistilli, Barbara Journal of Clinical Oncology, Vol.43 No.3, pp.285-296	DOI
2025-04	TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer Schmid, Peter; Oliveira, Mafalda; O'Shaughnessy, Joyce; Cristofanilli, Massimo; Graff, Stephanie L.; Im, Seock-Ah; Loi, Sherene; Saji, Shigehira; Wang, Shusen; Cescon, David W.; Hovey, Tina; Nawrot, Agata; Tse, Karson; Vukovic, Petra; Curigliano, Giuseppe Therapeutic Advances in Medical Oncology, Vol.17, p. 175883592513279	DOI

1